Vogt-Koyanagi-Harada disease.

Area of Science:

• Ophthalmology
• Immunology
• Autoimmune Diseases

Background:

• Vogt-Koyanagi-Harada disease is a severe bilateral granulomatous intraocular inflammation.
• It is an autoimmune condition mediated by T-cells targeting melanocytes.
• The disease presents in four phases with potential extraocular manifestations.

Purpose of the Study:

• To review the clinical presentation, diagnosis, and management of Vogt-Koyanagi-Harada disease.
• To highlight advances in imaging for earlier diagnosis.
• To emphasize the importance of prompt and aggressive treatment for favorable outcomes.

Main Methods:

• Review of current literature on Vogt-Koyanagi-Harada disease.
• Discussion of diagnostic advancements, particularly ocular coherence tomography.
• Outline of treatment strategies including corticosteroids and immunomodulatory drugs.

Main Results:

• Ocular coherence tomography is crucial for diagnosing acute and chronic Vogt-Koyanagi-Harada disease, showing exudative detachments, choroidal thickening, and thinning.
• Early diagnosis and aggressive treatment are associated with good final visual outcomes.
• Potential complications include cataracts, glaucoma, and subretinal fibrosis.

Conclusions:

• Vogt-Koyanagi-Harada disease requires prompt and aggressive management.
• Advances in imaging and treatment have improved patient outcomes.
• Effective management can prevent severe visual impairment and long-term complications.